Oppenheimer & Co’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-788
| Closed | -$6K | – | 1452 |
|
|
2022
Q3 | $6K | Hold |
788
| – | – | ﹤0.01% | 1357 |
|
|
2022
Q2 | $17K | Hold |
788
| – | – | ﹤0.01% | 1392 |
|
|
2022
Q1 | $30K | Hold |
788
| – | – | ﹤0.01% | 1453 |
|
|
2021
Q4 | $44K | Buy |
788
+270
| +52% | +$15.1K | ﹤0.01% | 1469 |
|
|
2021
Q3 | $37K | Sell |
518
-120
| -19% | -$8.57K | ﹤0.01% | 1474 |
|
|
2021
Q2 | $61K | Buy |
638
+100
| +19% | +$9.56K | ﹤0.01% | 1482 |
|
|
2021
Q1 | $79K | Buy |
+538
| New | +$79K | ﹤0.01% | 1408 |
|
|
2020
Q4 | – | Sell |
-690
| Closed | -$105K | – | 1419 |
|
|
2020
Q3 | $105K | Buy |
+690
| New | +$105K | ﹤0.01% | 1230 |
|